Use of expert consensus to improve the diagnosis and management of type 1 diabetes mellitus.

Publisher: Wolters Kluwer Health Country of Publication: Netherlands NLM ID: 101174817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1728-7731 (Electronic) Linking ISSN: 17264901 NLM ISO Abbreviation: J Chin Med Assoc Subsets: MEDLINE

Publication: 2019- : [Alphen aan den Rijn, The Netherlands] : Wolters Kluwer Health
Original Publication: Taipei, Taiwan : Chinese Medical Association, c2003-

Diabetes Mellitus, Type 1*/diagnosis ; Diabetes Mellitus, Type 1*/therapy; Adolescent ; Adult ; Child ; Consensus ; Humans ; Research Design

Background: Although type 1 diabetes mellitus (T1DM) is recognized as a catastrophic disease among the different types of diabetes, it is often confusedly diagnosed in clinical practice and difficult in care. The objective of this study is to reach a multidisciplinary consensus for the establishment of clinical recommendations on T1DM to optimize its undoubtedly diagnostic evaluation and transitional care.
Methods: Scientific evidence was reviewed by a committee of researchers, based on which recommendations related to T1DM diagnosis were formulated. A two-round method was conducted to compare the opinions of a panel of 32 specialists (adult endocrinologists [53.1%], pediatric endocrinologists [43.8%], a diabetes educator for child and adolescent [3.1%]) on these issues.
Results: The panel reached consensus on two of the six items discussed. The four items on which no consensus was reached were related to autoantibody detection and age of onset. Up to 80% of the panelists favored items related to the glucagon test and diabetic ketoacidosis history for T1DM diagnosis. Consensus regarding transitional care through diabetes educators was established.
Conclusion: The assessment conducted by experts on T1DM showed a high level of professional agreement regarding the proposed diagnostic and transitional care recommendations. A comprehensive analysis of the latest evidence is warranted for the items on which consensus was not established.
Competing Interests: Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
(Copyright © 2022, the Chinese Medical Association.)

Jiang YD, Chang CH, Tai TY, Chen JF, Chuang LM. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database. J Formos Med Assoc. 2012;111:599–604.
Sheen YJ, Hsu CC, Jiang YD, Huang CN, Liu JS, Sheu WH. Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan. J Formos Med Assoc. 2019;118(Suppl 2):66–73.
World Health Organization. Classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 2019.
Steurer J. The Delphi method: an efficient procedure to generate knowledge. Skeletal Radiol. 2011;40:959–61.
Chiang YT, Yu HY, Lo FS, Chen CW, Huang TT, Chang CW, et al. Emergence of a butterfly: the life experiences of type 1 diabetes Taiwanese patients during the 16-25 years old transition period. Int J Qual Stud Health Well-Being. 2020;15:1748362.
Bonifacio E, Achenbach P. Birth and coming of age of islet autoantibodies. Clin Exp Immunol. 2019;198:294–305.
Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Weets I, et al.; Belgian Diabetes Registry. IA-2 autoantibodies predict impending type I diabetes in siblings of patients. Diabetologia. 2002;45:1658–66.
Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes. Diabetes. 2005;54(Suppl 2):S52–61.
Dabelea D, Pihoker C, Talton JW, D’Agostino RB Jr, Fujimoto W, Klingensmith GJ, et al.; SEARCH for Diabetes in Youth Study. Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2011;34:1628–33.
Juang JH, Huang BY, Huang HS, Lin JD, Huang MJ. C-peptide response to glucagon in young diabetics. Taiwan Yi Xue Hui Za Zhi. 1989;88:579–83.
Leighton E, Sainsbury CA, Jones GC. A practical review of C-peptide testing in diabetes. Diabetes Ther. 2017;8:475–87.
Steck AK, Johnson K, Barriga KJ, Miao D, Yu L, Hutton JC, et al. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care. 2011;34:1397–9.
Tung YC, Chen MH, Lee CT, Tsai WY. Beta-cell autoantibodies and their function in Taiwanese children with type 1 diabetes mellitus. J Formos Med Assoc. 2009;108:856–61.
Tung YC, Lee JS, Tsai WY, Hsiao PH. Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test. Eur J Pediatr. 2008;167:801–5.
Dabelea D, Rewers A, Stafford JM, Standiford DA, Lawrence JM, Saydah S, et al.; SEARCH for Diabetes in Youth Study Group. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133:e938–45.
Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44:S15–33.
Eisenbarth GS. Update in type 1 diabetes. J Clin Endocrinol Metab. 2007;92:2403–7.
Buschur EO, Glick B, Kamboj MK. Transition of care for patients with type 1 diabetes mellitus from pediatric to adult health care systems. Transl Pediatr. 2017;6:373–82.

Investigator: TJ Chang; BH Chen; PC Chiu; JF Chen; YJ Chen; DM Chu; BY Huang; C Gung; CN Huang; YY Ke; PJ Hsiao; CM Hwu; FC Kuo; TI Lee; CH Lin; CL Lin; YJ Lee; FS Lo; HY Ou; TY Tai; MC Tsai; ST Tsai; ST Tu; HF Wang; YC Tung; JS Wang; SL Wong; YL Wu

Date Created: 20220601 Date Completed: 20220707 Latest Revision: 20230727

20240105

10.1097/JCMA.0000000000000751

35648167